2 videos

Biomarkers in HER2-Positive breast cancer: from the IHC Era to multi-omics in tissue and blood

Dr. Juan Miguel Cejalvo: University Clinic Hospital, Valencia/INCLIVA

Dr. Pablo Tolosa University Hospital October 12, Madrid

2 videos

Integration of clinically available biomarkers for treatment escalation or de-escalation in early and advanced HER2-Positive breast cancer

Dr. Tomás Pascual: Hospital Clínic, Barcelona

Dr. Mireia Margelí: Catalan Institute of Oncology, Barcelona

2 videos

Changing the paradigm of first-line treatment: integrating the latest evidence to optimize patient care

Dr. Sibylle Loibl: German Breast Group, Neu-Isenburg, Germany

Dr. Cristina Saura: Vall d’Hebron University Hospital, Barcelona

2 videos

Enhancing second-line treatment options and beyond: navigating current approved therapies and promising emerging drugs

Dr. Sonia Pernas: Catalan Institute of Oncology, Barcelona

Dr. Rodrigo Sánchez-Bayona: University Hospital October 12, Madrid

2 videos

Cutting-edge approaches to enhancing quality of life: proactive adverse event management and education programs

Dr. Nadia Harbeck: LMU University Hospital, Munich

Dr. Santiago Escrivá: Vall d’Hebron University Hospital, Barcelona